Anzeige
Mehr »
Login
Mittwoch, 22.01.2020 Börsentäglich über 12.000 News von 622 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 4842 ISIN: US52886N3070 Ticker-Symbol:  
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
LEXARIA BIOSCIENCE CORP Chart 1 Jahr
5-Tage-Chart
LEXARIA BIOSCIENCE CORP 5-Tage-Chart

Aktuelle News zur LEXARIA BIOSCIENCE Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DiLebensretter: Unsere "GW Pharma 3.0" Biotechperle entwickelt innovative Therapien bei Herzerkrankungen auf Basis von Cannabinoiden!
14.01.Buds & Duds: Lexaria Bioscience shines while Aphria tumbles on slashed revenue outlook8
14.01.Lexaria Bioscience strikes licensing pact to provide DehydraTECH technology to Cannadips CBD-
LEXARIA BIOSCIENCE Aktie jetzt für 4€ handeln
14.01.Lexaria Bio teams up with Cannadips for CBD oral pouch & dip category-
14.01.Lexaria Biosciences and Cannadips CBD Announce Definitive Technology Licensing agreement for CBD Oral Pouch & Dip Category2
14.01.Lexaria Bioscience Corp. and Cannadips CBD Announce Definitive Technology Licensing agreement for CBD Oral Pouch & Dip Category208KELOWNA, BC / ACCESSWIRE / January 14, 2020 / Lexaria Bioscience Corp. (OTCQX:LXRP)(CSE:LXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, announces that it has reached...
► Artikel lesen
09.01.NA Proactive news snapshot: Surge Holdings, Flowr, Hillcrest Petroleum, Lexaria Bioscience UPDATE …2
09.01.Lexaria Bioscience Corp. - 8-K, Current Report-
09.01.Lexaria Bioscience planning to list on a major US exchange in 2020, says CEO-
09.01.Lexaria Provides Strategic Update from CEO-
09.01.Lexaria Bioscience Corp: Lexaria hopes to double fiscal 2019 revenue in 2020-
09.01.Lexaria Bioscience Corp.: Lexaria Provides Strategic Update from CEO321KELOWNA, BC / ACCESSWIRE / January 9, 2020 / Lexaria Bioscience Corp. (OTCQX:LXRP) (CSE:LXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, announces the following strategic...
► Artikel lesen
30.12.19NA Proactive news snapshot: Nextleaf Solutions Ltd, GoviEx Uranium Inc, Great Panther Mining Ltd, Lexaria Bioscience Corp UPDATE ...26
30.12.19Lexaria Awards Options-
02.12.19Lexaria Bioscience Corp. - 8-K, Current Report-
29.11.19Lexaria Bioscience Corp: Lexaria closes second tranche of financing-
29.11.19Lexaria Announces 2nd Tranche Closing of Non-Brokered Private Placement-
21.11.19Lexaria Bioscience further enhances drug delivery platform as human tests show it delivers THC within 10 minutes-
21.11.19Lexaria Bioscience Corp: Lexaria's DehydraTech works in less than 10 minutes-
21.11.19Lexaria's Technology Now Works in Less Than 10 Minutes-
Seite:  Weiter >>
113 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1